Glycomimetic affinity-enrichment proteomics identifies partners for a clinically-utilized iminosugar

Glycomimetic affinity-enrichment proteomics identifies partners for a clinically-utilized iminosugar

Widescale evaluation of interacting partners for carbohydrates is an underexploited area. Probing of the 'glyco-interactome' has particular relevance given the lack of direct genetic control of glycoconjugate biosynthesis. Here we design, create and utilize a natural product-derived glycom...

Bibliográfalaš dieđut
Váldodahkkit:	Cruz, I, Barry, C, Kramer, H, Chuang, C, Lloyd, S, van der Spoel, A, Platt, F, Yang, M, Davis, B
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	2013

Geahča maid

Targeting Galectins With Glycomimetics
Dahkki: Sara Bertuzzi, et al.
Almmustuhtton: (2020-08-01)

Glycomimetic probes for studying carbohydrate-protein interactions
Dahkki: Davis, B
Almmustuhtton: (2005)

Glycosaminoglycans and Glycomimetics in the Central Nervous System
Dahkki: Dáire Rowlands, et al.
Almmustuhtton: (2015-02-01)

Glycomimetics and Glycoconjugates in Drug Discovery
Dahkki: Nuno M. Xavier, et al.
Almmustuhtton: (2024-03-01)

Glycomimetic Peptides as Therapeutic Tools
Dahkki: J. Kenneth Hoober, et al.
Almmustuhtton: (2023-02-01)

Diversity-oriented synthesis of glycomimetics
Dahkki: Michael Meanwell, et al.
Almmustuhtton: (2021-06-01)

Iminosugar inhibitors for treating the lysosomal glycosphingolipidoses
Dahkki: Butters, T, et al.
Almmustuhtton: (2005)

Strategies for the Development of Glycomimetic Drug Candidates
Dahkki: Rachel Hevey
Almmustuhtton: (2019-04-01)

Glycomimetics: Design, Synthesis, and Therapeutic Applications
Dahkki: Philippe Compain
Almmustuhtton: (2018-07-01)

Mechanistic insight into enzymatic glycosyl transfer with retention of configuration through analysis of glycomimetic inhibitors.
Dahkki: Errey, J, et al.
Almmustuhtton: (2010)

Drug Discovery Based on Fluorine-Containing Glycomimetics
Dahkki: Xingxing Wei, et al.
Almmustuhtton: (2023-09-01)

Bioisosteres of Carbohydrate Functional Groups in Glycomimetic Design
Dahkki: Rachel Hevey
Almmustuhtton: (2019-07-01)

Glycomimetic inhibitors of mycobacterial glycosyltransferases: targeting the TB cell wall.
Dahkki: Lucas, R, et al.
Almmustuhtton: (2008)

Iminosugar for treatment of tumors
Dahkki: Dwek, R, et al.
Almmustuhtton: (2008)

A Specific, Glycomimetic Langerin Ligand for Human Langerhans Cell Targeting
Dahkki: Eike-Christian Wamhoff, et al.
Almmustuhtton: (2019-05-01)

Affinity-Enriched Plasma Proteomics for Biomarker Discovery in Abdominal Aortic Aneurysms
Dahkki: Nicolai Bjødstrup Palstrøm, et al.
Almmustuhtton: (2024-12-01)

The mechanism of action of iminosugars as antiretrovirals
Dahkki: Spiro, S, et al.
Almmustuhtton: (2014)

The synthesis and biology of iminosugars and their precursors
Dahkki: Ayers, B, et al.
Almmustuhtton: (2014)

The synthesis of branched sugars and iminosugars
Dahkki: Parry, LL
Almmustuhtton: (2011)

Total asymmetric syntheses of iminosugars
Dahkki: Figuccia, A, et al.
Almmustuhtton: (2015)

Lucerastat, an iminosugar for substrate reduction therapy in Fabry disease: preclinical evidence
Dahkki: Priestman, D, et al.
Almmustuhtton: (2017)

Antiviral effects of an iminosugar derivative on flavivirus infections.
Dahkki: Wu, S, et al.
Almmustuhtton: (2002)

Lucerastat, an iminosugar for substrate reduction therapy in Fabry Disease: Preclinical evidence
Dahkki: Welford, R, et al.
Almmustuhtton: (2017)

A stabilized glycomimetic conjugate vaccine inducing protective antibodies against Neisseria meningitidis serogroup A
Dahkki: Jacopo Enotarpi, et al.
Almmustuhtton: (2020-09-01)

Iminosugars and methods of treating Arenaviral infections
Dahkki: Ramstedt, U, et al.
Almmustuhtton: (2010)

Iminosugars and methods of treating viral diseases
Dahkki: Ramstedt, U, et al.
Almmustuhtton: (2011)

Iminosugars: promising therapeutics for influenza infection
Dahkki: Tyrrell, B, et al.
Almmustuhtton: (2016)

Iminosugar antivirals: the therapeutic sweet spot
Dahkki: Alonzi, D, et al.
Almmustuhtton: (2017)

Iminosugars : from synthesis to therapeutic applications /
Dahkki: Compain, Philippe, et al.
Almmustuhtton: (2007)

Iminosugars and methods of treating Filoviral diseases
Dahkki: Ramstedt, U, et al.
Almmustuhtton: (2011)

Iminosugars as therapeutic agents: recent advances and promising trends.
Dahkki: Nash, R, et al.
Almmustuhtton: (2011)

Affinity Proteomics Identifies Interaction Partners and Defines Novel Insights into the Function of the Adhesion GPCR VLGR1/ADGRV1
Dahkki: Barbara Knapp, et al.
Almmustuhtton: (2022-05-01)

Publisher Correction: A stabilized glycomimetic conjugate vaccine inducing protective antibodies against Neisseria meningitidis serogroup A
Dahkki: Jacopo Enotarpi, et al.
Almmustuhtton: (2020-11-01)

Iminosugars and methods of treating Bunyaviral and Togaviral diseases
Dahkki: Ramstedt, U, et al.
Almmustuhtton: (2010)

The synthesis of azetidine and piperidine iminosugars from monosaccharides
Dahkki: Lenagh-Snow, G, et al.
Almmustuhtton: (2012)

Multivalent Pyrrolidine Iminosugars: Synthesis and Biological Relevance
Dahkki: Yali Wang, et al.
Almmustuhtton: (2022-08-01)

Glycomimetic antagonists of BC2L-C lectin: insights from molecular dynamics simulations
Dahkki: Giulia Antonini, et al.
Almmustuhtton: (2023-05-01)

A Novel Iminosugar UV-12 with Activity against the Diverse Viruses Influenza and Dengue (Novel Iminosugar Antiviral for Influenza and Dengue)
Dahkki: Kelly L. Warfield, et al.
Almmustuhtton: (2015-05-01)

A silver-lined anniversary of Fleet iminosugars: 1984-2009, from DIM to DRAM to LABNAc
Dahkki: Davis, B
Almmustuhtton: (2009)

Glycosphingolipid depletion in PC12 cells using iminosugars protects neuronal membranes from anti-ganglioside antibody mediated injury.
Dahkki: Townson, K, et al.
Almmustuhtton: (2008)